Infections with Pseudomonas aeruginosa have become a real concern in hospital-acquired
infections, especially in critically ill and immunocompromised patients. The major problem …

The increasing prevalence of chronic and hospital-acquired infections produced by
multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa …

Bacteriophage therapy has been suggested as an alternative or complementary strategy for
the treatment of multidrug resistant (MDR) bacterial infections. Here, we report the …

Background Long-term outbreaks of multidrug-resistant Gram-negative bacilli related to
hospital-building water systems have been described. However, successful mitigation …

Carbapenem antibiotics constitute the mainstay therapy of nosocomial infections with
extended spectrum beta-lactamase producing Gram-negative bacteria; however, resistance …

Objective The objective of this study was to investigate the antibiotic susceptibility, virulence
factors and clonal relationship among Pseudomonas aeruginosa isolated from …

Pseudomonas aeruginosa is one of the main pathogens responsible for nosocomial
infections, particularly in Intensive Care Units (ICUs). Due to the complexity of P. aeruginosa …

Objectives: Pseudomonas aeruginosa is a key opportunistic pathogen causing a wide range
of community-and hospital-acquired infections in immunocompromised or catheterized …

Background Pseudomonas aeruginosa is a leading cause of healthcare-associated
infections in the intensive care unit (ICU). Aim To investigate an unexplained increase in the …

Objective (s): Resistance to carbapenems is the principal reason for the continuing
utilization of colistin as a last resort choice for treating the infections resulted from multidrug …